Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News US Global Nanospace Inc USGA

US Global Nanospace, Inc. (USGN) is a research and development company. The Company specializes in identifying, developing, and commercializing new and emerging technologies and products for integration into the security, defense and health and safety markets. USGN uses cross-discipline information in the areas of science, engineering, nanotechnology and nanomaterials to evolve products. The... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (GREY:USGA)

No current news is available.

Opinion & Analysis (GREY:USGA)

No current opinion is available.

Bullboard Posts (GREY:USGA)

Kevin Harrington Discusses FSD Pharma

<< View Post To Watch Video >> I believe this new product will aid society in reducing the number of alcohol-related...
Sarahhh - April 13, 2023

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

 
Sarahhh - July 15, 2022

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

<< View Post To Watch Video >> FSD Pharma ready to proceed with Phase 2 clinical trial of FSD-201 as soon as it gets...
Sarahhh - June 3, 2022

FSD Pharma Files Investigational New Drug Application “IND”

Sarahhh - June 2, 2022

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

 
Sarahhh - May 11, 2022

Lucid-MS for Multiple Sclerosis Treatment

<< View Post To Watch Video >>
Sarahhh - May 3, 2022